Corbus Pharmaceuticals Holdings, Inc. Equity-NMS: CRBP

$5.31 -0.21 (April 1, 2025)

Healthcare

Biotechnology

Buy/Sell an entire stock
or a fraction.
Powered by Vested Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly
Loading, Please wait...
Error in Fetching Data, Please retry later.
No data available.
Previous close :$5.52
Open :$5.42
Today's high :$5.5
Today's low :$5.11
52W low :$5.11
52W high :$61.9
1Y :-84.58%
5Y :-96.29%
EPS(TTM): :-3.68
Shares O/S :12.23 M
Market cap :64.95 M

Compare with Other Stocks

Frequently Asked Questions

What is the share price of Corbus Pharmaceuticals Holdings, Inc. today?

Corbus Pharmaceuticals Holdings, Inc. (CRBP) share price as of April 1, 2025, is $5.78. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of Corbus Pharmaceuticals Holdings, Inc.?

Yes, Indian Investors can invest in the Corbus Pharmaceuticals Holdings, Inc. (CRBP) Share by opening an international trading account with Angel One.

How can I purchase Corbus Pharmaceuticals Holdings, Inc. shares in India?

Purchasing Corbus Pharmaceuticals Holdings, Inc. (CRBP) share from India can be done by:
  1. Directly: By opening an international trading account with Angel One. The process would include KYC verification.
    The account activation takes a few minutes to a few hours, after which you can start buying Corbus Pharmaceuticals Holdings, Inc. (CRBP) by making deposits in US dollars.
  2. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of Corbus Pharmaceuticals Holdings, Inc.?

Yes, you can purchase fractional shares of Corbus Pharmaceuticals Holdings, Inc. (CRBP) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of Corbus Pharmaceuticals Holdings, Inc.?

The market capitalization of Corbus Pharmaceuticals Holdings, Inc. on April 1, 2025, is $70.7 M.

In which sector Corbus Pharmaceuticals Holdings, Inc. belongs?

Corbus Pharmaceuticals Holdings, Inc. operates in the Healthcare sector, specifically in the Biotechnology industry.

What documents are required to invest in Corbus Pharmaceuticals Holdings, Inc. stocks?

In order to invest in Corbus Pharmaceuticals Holdings, Inc. (CRBP) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

About Corbus Pharmaceuticals Holdings, Inc.

Corbus Pharmaceuticals Holdings, Inc. is a precision oncology company with a diversified portfolio. The Company's pipeline is comprised of two experimental drugs targeting solid tumors: CRB-701, which is an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload and CRB-601, which is an anti-integrin monoclonal antibody that blocks the activation of TGFβ expressed on cancer cells. Its pipeline also includes CRB-913, which is a highly peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. It has in-licensed the intellectual property for CRB-601 from Dr. Stephen Nishimura's laboratory at the University of California, San Francisco. The Company does not own or operate manufacturing facilities and relies on third-party contract manufacturing organizations or licensing partners to supply it with drugs for pre-clinical and clinical studies and commercial activities.